EPCAM and cancer: Epithelial derived cancers account for 80–90% of malignancies, and it has been observed that CTCs found in patients with solid epithelial tumors express epithelial markers such as the epithelial cell adhesion molecule (EpCAM) and cytokeratin (CK).